"God's Secret Agent" no more, for one so blithe as to go to Him. Vale at atque! (Hale and Farewell)
----- on 03/13/2011 11:18 PM wrote:
>
Flower power drug icon dies in Australia: family
(AFP) #150; 1 hour ago
LOS ANGELES #151; Owsley "Bear" Stanley, who supplied LSD to the 1960s flower power generation and worked closely with psychedelic band The Grateful Dead, died Sunday in a car crash in Australia, his family said.
Stanley, who was 76, started as a sound engineer for the band and is credited with developing hifi technology which is now taken for granted, such as on-stage monitors for bands to hear themselves while playing.
But he was more remembered for the pure form of LSD he manufactured, fueling the flower power counter-culture which exploded out from San Francisco in the mid to late 1960s.
Stanley died when his car swerved off a road and slammed into a tree, media reports said. Queensland police said a 76-year-old died at the scene while his female passenger was taken to Cairns Base Hospital with minor injuries.
"We are extremely saddened to report that Owsley "Bear" Stanley, our beloved patriarch, died (Sunday) in an automobile accident near his home in Far North Queensland Australia," said a family statement
"The family asks for privacy while we deal with this tragedy," added the statement, issued by former Grateful Dead tour manager Sam Cutler.
The grandson of a former governor of Kentucky, Stanley was the original LSD "cook" who produced large quantities of LSD at his lab in San Franciso. He was arrested several times for drug making.
He briefly managed the Grateful Dead and oversaw their live sounds at a time when little thought was given sound systems in public arenas. His tape recordings of Dead concerts were turned into live albums.
Stanley reportedly became an Australian citizen in 1996 and lived near the northeastern Australian city of Cairns, where he worked as an artist, making gold and enamel sculptures.
He is survived by his wife Sheila, four children, eight grandchildren and two great-grandchildren.
Schering-Plough for sale in Europe psychotic drugs Asenapine
ReplyDeleteSchering-Plough Europe, Food and Drug Administration has submitted a New Drug Asenapine schizophrenia sales in research applications, the drug is a sublingual tablet. Some analysts believe that the drug in the European market is likely to become the best-selling products.
If the drug is ultimately approved for marketing in Europe, it will Sycrest trade names in local sales. This medication is used to treat schizophrenia and mania associated with bipolar disorder. The submission of a New Drug Application in the European context, including more than 3,000 patients were enrolled in a clinical data.
2008 at a meeting, Schering-Plough R & D department is responsible for claims, Asenapine great attention, it is considered that the company is in late stage clinical development of five stars in drug research world. At that time, Schering-Plough has said 2009 will be in Europe's listing application submitted to the drug, and this implementation of the plan in the drug development process is important.
Earlier this year, Schering-Plough received from the FDA Asenapine is a feedback letter recommends two drugs indications provide the appropriate label instructions, and asked for drugs to supplement existing clinical data, but did not request additional clinical experiment. If the drug is approved for marketing in the United States, it will Saphris trade names in local sales.
In November 2007, through the acquisition of Schering-Plough acquired Organon BioSciences Corporation and Asenapine permission.
Medchemexpress Can provide the above product,its website:www.medchemexpress.com
Lenalidomide
AZD1152-HQPA
ZM-447439
Tozasertib
PHA-680632
MLN8054
JNJ-7706621
CYC-116
CCT 137690
Alisertib